Use of nonprescription topical steroids: Patients' experiences

British Journal of Dermatology

Volumn 152, Issue 6, 2005, Pages 1193-1198

  Rogers, P J ^a   Wood, S M ^a   Garrett, E L ^b   Krykant, S P ^b   Haddington, N J ^c   Hayhurst, J ^d   Player, G R H ^e  

^a University of Bath   (United Kingdom)

^b ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^c ROYAL UNITED HOSPITAL   (United Kingdom)

^d OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Clobetasone; Eczema; Hydrocortisone; Nonprescribed medicines; Pharmacist; Pharmacy

Indexed keywords

ANTIFUNGAL AGENT; CLOBETASONE BUTYRATE; CLOTRIMAZOLE; CLOTRIMAZOLE PLUS HYDROCORTISONE; CORTICOSTEROID; CROTAMITON PLUS HYDROCORTISONE; DAKTACORT; HC 45; HYDROCORTISONE; NON PRESCRIPTION DRUG; STEROID; UNCLASSIFIED DRUG;

ACNE; ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANESTEN HC; CHILD; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; CREAM; DEMOGRAPHY; DERMATITIS; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG INDICATION; DRUG MARKETING; DRUG POTENCY; DRUG UTILIZATION; ECZEMA; FEMALE; HUMAN; INFANT; INFECTION; INSECT BITE; IRRITANT DERMATITIS; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTCOMES RESEARCH; PHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; QUESTIONNAIRE; RASH; SCORING SYSTEM; SELF MEDICATION; SKIN DISEASE; SKIN THINNING; THRUSH; TINEA PEDIS; UNITED KINGDOM; VAGINA THRUSH;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; CLOBETASOL; DERMATITIS; DRUG ADMINISTRATION SCHEDULE; DRUGS, NON-PRESCRIPTION; ECZEMA; FEMALE; GLUCOCORTICOIDS; GREAT BRITAIN; HUMANS; HYDROCORTISONE; INFANT; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; SELF ADMINISTRATION; SKIN DISEASES;

EID: 21644439787     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06513.x     Document Type: Article

References (16)

1. Department of Health. Pharmacy in the Future-Implementing the NHS Plan. London: Stationery Office, 2000.
2. Rogers PJ, Rees JE. Comparison of the use of PMRs in 1991 and 1995: (1) PMR use and recording of product details. Pharm J 1996; 256:161-6.
3. Bond C. POM to P switch-implications for practice pharmacists. Prim Care Pharm 2001; 8:5-7.
4. Blenkinsopp A, Bradley C. Over the counter drugs: patients, society, and the increase in self medication. Br Med J 1996; 312:629-32.
5. Bellingham C. Proper use of topical corticosteroids. Pharm J 2001; 267:377.
6. Editorial. OTC hydrocortisone. Pharm J 1987; 238:153.
7. Emerson RM, Charman CR, Williams HC. The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading. Br J Dermatol 2000; 142:288-97.
8. Charman C, Williams H. Outcome measures of disease severity in atopic eczema. Arch Dermatol 2000; 136:763-9.
9. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol (Stockh) 1989; 144:13-14.
10. Williams HC. Epidemiology of atopic dermatitis. Clin Exp Dermatol 2000; 25:522-9.
11. Community Pharmacy: the Choice Is Yours. London: Royal Pharmaceutical Society of Great Britain, March 1996.
12. http://www.statistics.gov.uk/census2001/annexb.asp (accessed 28 May 2004).
13. Hibbert D, Bissell P, Ward PR. Consumerism and professional work in the community pharmacy. Sociol Health Illness 2002; 24:46-65.
14. Wilson M, Robinson EJ, Blenkinsopp A, Panton R. Customers' recall of information given in community pharmacies. Int J Pharm Prac 1992; 1:152-9.
15. Gray N, Cantrill J, Noyce PR. Mass media health information available to young adults in the United Kingdom. Int J Pharm Prac 1998; 6:180-95.
16. Bond C, Hannaford P. Issues related to monitoring the safety of over-the-counter (OTC) medicines. Drug Saf 2003; 26:1065-74.